Is COVID-19 receiving ADE from other coronaviruses?

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorTetro, Jason A.-
Data de aceite: dc.date.accessioned2026-02-09T12:02:40Z-
Data de disponibilização: dc.date.available2026-02-09T12:02:40Z-
Data de envio: dc.date.issued2020-03-26-
Data de envio: dc.date.issued2020-03-26-
Data de envio: dc.date.issued2020-03-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/39433-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1286457920300344-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1153096-
Descrição: dc.descriptionOne of the most perplexing questions regarding the current COVID-19 coronavirus epidemic is the discrepancy between the severity of cases observed in the Hubei province of China and those occurring elsewhere in the world. One possible answer is antibody dependent enhancement (ADE) of SARS-CoV-2 due to prior exposure to other coronaviruses. ADE modulates the immune response and can elicit sustained inflammation, lymphopenia, and/or cytokine storm, one or all of which have been documented in severe cases and deaths. ADE also requires prior exposure to similar antigenic epitopes, presumably circulating in local viruses, making it a possible explanation for the observed geographic limitation of severe cases and deaths.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceMicrobes and Infection-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectCoronavirus-
Palavras-chave: dc.subjectAntibody dependent enhancement (ADE)-
Título: dc.titleIs COVID-19 receiving ADE from other coronaviruses?-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.